Changchun Xinuo BioTechnology Co., Ltd. was established in October 2005. The company is located in Changchun High-tech Industrial Development Zone, Jilin Province, with a registered capital of 21.25 million yuan. It is a high-tech enterprise specializing in the research and development and production of veterinary biological products and their raw and auxiliary materials. The company has three GMP production lines for veterinary blood products, veterinary diagnostic products and newborn bovine serum. It has two research and development platforms for genetic engineering vaccines and rapid diagnostic reagents. Relying on the academician workstation, it specializes in the development of biological products related to infectious diseases of small animals such as dogs and cats. The products cover three categories: prevention, diagnosis and treatment. The company has obtained eight invention patent authorizations, five new veterinary drug certificates, ten clinical approvals, undertook five national key scientific and technological research and development projects in the 13th Five-Year Plan period, and signed 13 cooperative development and technology transfer contracts. While insisting on independent research and development, the company has also established good cooperative relations with a number of scientific research institutes and production enterprises, with complementary advantages and win-win cooperation. Changchun Xinuo BioTechnology Co., Ltd. promises to protect the health of pets and benefit human life. Determined to become a leader in China's pet health industry!